Matrix stiffness affects spontaneous contraction of cardiomyocytes cultured within a PEGylated fibrinogen biomaterial.

Successful implementation of cardiac cell transplantation for treating damaged myocardium relies on the development of improved injectable biomaterials. A novel biomaterial technology using PEGylated fibrinogen has been developed with controllable physicochemical properties based on the poly(ethylene glycol) (PEG) constituent. In addition, the fibrinogen backbone of the material confers inherent bioactivity to cells. The purpose of this investigation was to explore by in vitro techniques the use of this biomaterial as a scaffold for cardiac tissue regeneration. To this end neonatal rat cardiomyocytes were cultivated in PEGylated fibrinogen constructs. The cell-seeding density and biomaterial composition were optimized to obtain maximum spontaneous contraction of the constructs. Quantitative characterization of the contraction pattern was accomplished by video image analysis. It was possible to demonstrate an inverse correlation between the material stiffness and the amplitude of contraction of the tissue constructs by changing the modulus of the matrix using different compositions of PEG and fibrinogen. The relationship between matrix stiffness, cell density and tissue contraction also provided some insight into the mechanism of cellular remodeling that ultimately leads to synchronized contraction of the constructs. These findings indicate that PEGylated fibrinogen hydrogels can be used as a scaffold for cardiomyocytes, and offer the possibility of controlling cellular remodeling via simple compositional modifications to the matrix.

[1]  Andreas Hess,et al.  Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts , 2006, Nature Medicine.

[2]  Todd C McDevitt,et al.  Spatially organized layers of cardiomyocytes on biodegradable polyurethane films for myocardial repair. , 2003, Journal of biomedical materials research. Part A.

[3]  H. Bianco-Peled,et al.  The effect of structural alterations of PEG-fibrinogen hydrogel scaffolds on 3-D cellular morphology and cellular migration. , 2006, Biomaterials.

[4]  D. Seliktar,et al.  Extracellular Stimulation in Tissue Engineering , 2005, Annals of the New York Academy of Sciences.

[5]  R. Ian Freshney,et al.  Culture of cells for tissue engineering , 1994 .

[6]  J. Hubbell,et al.  Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering , 2005, Nature Biotechnology.

[7]  J. Vacanti,et al.  Contractile cardiac grafts using a novel nanofibrous mesh. , 2004, Biomaterials.

[8]  C. Murry,et al.  Muscle cell grafting for the treatment and prevention of heart failure. , 2002, Journal of cardiac failure.

[9]  D. Seliktar,et al.  A novel poly(ethylene glycol)-fibrinogen hydrogel for tibial segmental defect repair in a rat model. , 2007, Journal of biomedical materials research. Part A.

[10]  D. Seliktar,et al.  Biosynthetic hydrogel scaffolds made from fibrinogen and polyethylene glycol for 3D cell cultures. , 2005, Biomaterials.

[11]  Milica Radisic,et al.  Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Theo Kofidis,et al.  Novel Injectable Bioartificial Tissue Facilitates Targeted, Less Invasive, Large-Scale Tissue Restoration on the Beating Heart After Myocardial Injury , 2005, Circulation.

[13]  S. Fazel,et al.  Current status of cellular therapy for ischemic heart disease. , 2005, The Annals of thoracic surgery.

[14]  H. Mertsching,et al.  Clinically established hemostatic scaffold (tissue fleece) as biomatrix in tissue- and organ-engineering research. , 2003, Tissue engineering.

[15]  Larry Kedes,et al.  Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. , 2002, Journal of molecular and cellular cardiology.

[16]  Randall J Lee,et al.  Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. , 2004, Journal of the American College of Cardiology.

[17]  J. Elisseeff,et al.  Immobilized fibrinogen in PEG hydrogels does not improve chondrocyte‐mediated matrix deposition in response to mechanical stimulation , 2006, Biotechnology and bioengineering.

[18]  Wolfram-Hubertus Zimmermann,et al.  Cardiac Tissue Engineering for Replacement Therapy , 2003, Heart Failure Reviews.

[19]  Richard T. Lee,et al.  Custom Design of the Cardiac Microenvironment With Biomaterials , 2005, Circulation research.

[20]  Paul N Manson,et al.  Variable cytocompatibility of six cell lines with photoinitiators used for polymerizing hydrogels and cell encapsulation. , 2005, Biomaterials.

[21]  Smadar Cohen,et al.  Renovation of the injured heart with myocardial tissue engineering , 2006, Expert review of cardiovascular therapy.

[22]  Richard T. Lee,et al.  Injectable Self-Assembling Peptide Nanofibers Create Intramyocardial Microenvironments for Endothelial Cells , 2005, Circulation.

[23]  K. Weber,et al.  Infarct scar: a dynamic tissue. , 2000, Cardiovascular research.

[24]  Malte Tiburcy,et al.  Heart muscle engineering: an update on cardiac muscle replacement therapy. , 2006, Cardiovascular research.

[25]  W. Zimmermann,et al.  Tissue Engineering of a Differentiated Cardiac Muscle Construct , 2002, Circulation research.

[26]  L Gepstein,et al.  Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. , 2001, The Journal of clinical investigation.

[27]  A. Murat Tekalp,et al.  Digital Video Processing , 1995 .